Lilly to invest further $450m to expand capacity at Research Triangle Park
Eli Lilly and Company (Lilly) is planning to invest an additional $450 million to increase the company’s production capacity at its Research Triangle Park facility in North Carolina. The proposed expansion is expected to help the American pharmaceutical company meet increased demand for its incretin products for diabetes and introduce the next generation of medicines. […]